Parnax Lab

Parnax Lab EBITDA per Share

The EBITDA per Share of Parnax Lab (506128.BO) as of Nov 18, 2026 is 23.63 INR. In the previous year, EBITDA per Share was 20.51 INR — a change of 15.19% (higher).

EBITDA per Share

23.63INR

YoY

15.19%

Last updated:

EBITDA per Share of Parnax Lab is 2025 23.63 INR. EBITDA per Share of Parnax Lab was 2024 20.51 INR. It decreases by 15.19% higher compared to the previous year.

The Parnax Lab EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
13.17 INR
Jan 1, 2019
12.02 INR
Jan 1, 2020
7.57 INR
Jan 1, 2021
11.70 INR
Jan 1, 2022
27.06 INR
Jan 1, 2023
20.84 INR
Jan 1, 2024
20.51 INR
Jan 1, 2025
23.63 INR
The Parnax Lab EBITDA per Share history
YEAREBITDA per ShareYoY
23.63INR+15.19%
20.51INR-1.57%
20.84INR-22.97%
27.06INR+131.34%
11.70INR+54.57%
7.57INR-37.04%
12.02INR-8.72%
13.17INR-12.27%
15.01INR+23.48%
12.15INR-17.79%
14.78INR+35.01%
10.95INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab Stock analysis

What does Parnax Lab do? Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems. Parnax Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Parnax Lab stock

EBITDA per Share of Parnax Lab is 23.63 INR in 2025.

EBITDA per Share of Parnax Lab changed from 20.51 INR to 23.63 INR, representing a 15.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Parnax Lab since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Parnax Lab

All Key Metrics — Parnax Lab